Publication | Open Access

Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

MedicineCancer ManagementGynecologyMaintenance TherapyBrca 1–2Cancer TreatmentOncologyRadiation OncologyMolecular OncologyEndocrine-related CancerOvarian CancerReal World Data